Diagnosis of Superficial Lymphadenopathy

ULTRASOUND Clinical Trial

Official title:

SMI and CEUS in the Diagnosis of Superficial Lymphadenopathy

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT04928560
• Other study ID #: 2020-588
• Status: Active, not recruiting
• Start date: September 1, 2020
• Est. completion date: December 30, 2022

Study information

• Verified date: September 2020
• Source: Second Affiliated Hospital, School of Medicine, Zhejiang University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study is to study the application of CEUS and SMI technology in superficial lymph node lesions (metastasis, lymphoma, inflammation, etc.), and to provide some diagnostic ideas for non-invasive diagnosis of lymph node lesions.

Description:

CEUS and SMI technology were used to evaluated the superficial lymph node lesions (metastasis, lymphoma, inflammation, etc.), and to provide some diagnostic ideas for non-invasive diagnosis of lymph node lesions.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 500
• Est. completion date: December 30, 2022
• Est. primary completion date: December 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

1. Age = 18 years old and = 80 years old;

2. Patients with enlarged lymph nodes detected by ultrasound;

3. No contraindications such as hypersensitivity to contrast-enhanced ultrasound;

4. Voluntarily enrolled in this research project

Exclusion Criteria:

• The patient's position cannot be matched during ultrasound examination

• Treatment history of lesion area: operation, radiotherapy, intervention, etc ? Patients without informed consent ? Lack of clinical data (no effective images such as two-dimensional ultrasound, color Doppler, contrast-enhanced ultrasound, micro blood flow imaging, or poor image quality, unable to analyze, unknown pathological results, etc.) ? Lack of follow up information

Related Conditions & MeSH terms

• Lymphadenopathy
• ULTRASOUND

Intervention

Diagnostic Test:
• SMI
ULTRASOUND

Locations

Country	Name	City	State
China	ZJU	Hangzhou	Zhejiang

Sponsors (1)

Lead Sponsor	Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	PATHOLOGY	BIOPSY/SURGERY	up to 3 months